Find us on Social Media

Latest News

Just launched! Visit our NEW online resource center for families and caregivers.


Aine’s 4th Annual Fashion Show Fundraiser March 30th, 2017 – Always a great night for a great cause. Don’t miss out, last year sold out! Read More >


Rudy Tanzi to Study Why Women Get Alzheimer’s More Than Men Read More >


Investigational new drug for Alzheimer’s scheduled for first study in humans Read More >


Viewpoint: Carey Mulligan’s campaign to change how we view dementia Read More >


Rudy Tanzi Speaks to Boston Business Journal:
Alzheimer’s Treatment Steps Closer Into View, Thanks to a Massachusetts Nonprofit ~ May 27, 2016

A year-and-a-half after discovering how Alzheimer’s begins, Rudolph Tanzi has figured out another key question: why does it take root?  Read More


A Cure for Alzheimer’s? ~ March 3, 2016

In a time of tight budgets and widespread demand for less government spending, Congress, the White House and a growing number of candidates for president from both parties agree that at least one priority should receive more money – research into the causes and possible cures of Alzheimer’s disease…Read more


Drs. Rudy Tanzi and Doo Yeon Kim Receive Smithsonian Ingenuity Award  ~ December 10, 2015

Cure Alzheimer’s Fund is thrilled to extend our congratulations to the chair of our Research Consortium, Dr. Rudy Tanzi, and to Dr. Doo Yeon Kim, for receiving the prestigious Smithsonian Magazine American Ingenuity Award…. Read more


As A Father’s Alzheimer’s Progresses, Family Learns To Love Him As He Is ~ October 03, 2015

In this installment of NPR’s series Inside Alzheimer’s, we’re sharing a recent video of Greg O’Brien at home on Cape Cod, Mass. A longtime journalist, O’Brien was diagnosed with early-onset Alzheimer’s disease in 2009… Read more


People Power: A Better World for People with Alzheimer’s ~ June 19, 2015

Kathy Broggy heard shouts. Then she saw a crowd gathered around a car. Inside, an older woman, who had Alzheimer’s, had forgotten how to get out. But the bystanders’ well-intentioned yelling only made her more confused. “It just made me heartsick,” says Broggy, the activity director for a small eldercare company in Knoxville, Tenn. “Nobody understood the basic dos and don’ts about helping people with Alzheimer’s.”…Read more


Promising New Alzheimer’s Drug Validates Anti-Amyloid Approach  ~ Mar. 23, 2015

As reported recently in the New York Times (Business Day, March 20, 2015, “Biogen Reports Its Alzheimer’s Drug Sharply Slows Cognitive Decline”) and other media, the pharmaceutical company Biogen has announced impressive results in a Phase I “human safety” trial of a new drug designed to treat — and possibly prevent — Alzheimer’s disease… Read more


Sleep Regulation Protein a Promising Target for Preventing Alzheimer’s  ~ Dec. 4th, 2014

New research by David Holtzman, M.D. at the Washington University School of Medicine points to a sleep regulation protein in the brain as a possible target for Alzheimer’s disease treatment or prevention… Read more


The Cure Alzheimer’s Fund Announces A Trio of Breakthroughs ~ Nov. 10th, 2014

Recent months have witnessed three remarkable developments in projects supported by Cure Alzheimer’s Fund. A team led by Research Consortium Chair Rudy Tanzi, Ph.D., has, for the first time, created “Alzheimer’s in a dish”—a combination of both amyloid and tau pathology in human nerve cells living inside a Petri dish… Read more


Are Brain Cell Regeneration Drugs Ready for Prime Time? ~ Aug. 12, 2014
A promising first-in-class drug stimulates the creation of new nerve cells in the brains of Alzheimer’s mice and will soon be tested in the brains of human patients, thanks to new research by Dr. Sam Gandy, member of Cure Alzheimer’s Fund’s Research Consortium, at Mount Sinai School of Medicine in New York. A new article by Gandy’s team just published in the journal Molecular Psychiatry outlines the extraordinary… Read more


Alzheimer’s Hits Women Hardest, Report Finds ~ March 18th 2014
Women are carrying the bigger burden of Alzheimer’s disease in the U.S., according to a new report — making up not only most of the cases, but paying more of the cost of caring for the growing population of people with the mind-destroying illness. The new report from the Alzheimer’s Association paints Alzheimer’s as a disease that disproportionately affects women, both as patients and as caregivers. It points out that women in their 60s are about twice as likely to develop Alzheimer’s over the rest of their lives as they are to develop breast cancer. Read more


The Economic Ripple Effect of Alzheimers Disease ~ March 18th 2014
Because it is an aging disease, concern about Alzheimer’s is mostly (and rightly) focused on patients and their families. But Alzheimer’s can also have a significant impact on the worldwide business community. As the Baby Boomer generation ages, the workforce is aging, too; and many Americans are delaying their retirements due to ongoing financial uncertainties. Serving as caregivers for ailing parents, relatives or even spouses adds to their financial and emotional burdens. For this reason, Alzheimer’s has become a growing national concern. Read more


Seth Rogen, Dennis Moore Testify at Senate Appropriations Subcommittee Hearing ~ February 26th 2014
Today, the Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing dedicated to the economic impact of Alzheimer’s disease in America. Chaired by Senators Tom Harkin (D-IA) and Jerry Moran (R-KS), the hearing also examined the current state of biomedical research into prevention and treatment of the disease. National Institutes of Health (NIH) Director Dr. Francis Collins, former Congressman Dennis Moore (D-KS), who is living with Alzheimer’s, and Alzheimer’s Association celebrity Champion Seth Rogen testified about the importance of funding Alzheimer’s research. Read more


Diagnosing Alzheimer’s: New Blood Test Suggests Possible Breakthrough
April 28th 2014
A new blood test, which has the potential to accurately diagnose Alzheimer’s disease in individuals and significantly advance drug testing and research on the disease, has been developed through grant funding by Cure Alzheimer’s Fund. Read More >



Back to Top